Follow-up With Preimplantation Genetic Testing Patients
Study Details
Study Description
Brief Summary
The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Purpose: To perform longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT.
Background: Preimplantation Genetic Testing (PGT) is a commercially available adjunct to in vitro fertilization (IVF) and is now performed in over 40% of treatment cycles in the United Sates (Society for Assisted Reproductive Technology Annual Report, 2018). Several clinical genetics entities offer PGT services, including Genomic Prediction Clinical Laboratory (CLIA# 31D2152380, CAP# 8488628). It is common practice to perform interviews with, and record reviews of patients following clinical interventions. Results may provide instrumental information for the scientific and medical community to improve clinical care. We would like to review medical records in order to recruit patients to participate in longitudinal studies of clinical outcomes and personal perspectives following utilization of PGT.
Study Design and Methods: Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. Patients who opted out of participating in research during informed consent to perform PGT will be ineligible for inclusion. Clinical PGT consent forms will be reviewed to identify patients that indicated willingness to participate in research. Eligible patients will be counseled on the study and consented for participation by a licensed genetic counselor. A total of 10,000 patients will be recruited. Following patient recruitment and informed consent, patient records and results of patient interviews may be used for publication in peer-reviewed scientific journals, presentation at scientific conferences or company meetings. As it is in standard practice, all external communication of results will maintain de-identification of all protected health information of all subjects (HIPAA guidelines). A licensed genetic counselor will conduct a recorded interview. Patient PGT, family history, and ethnicity data and information may be included in cohort analyses.
Study Design
Outcome Measures
Primary Outcome Measures
- Patient perspectives on PGT [2 years]
Analysis of interview responses
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients indicating willingness to participate in research during informed consent to perform PGT
Exclusion Criteria:
- Patients who opted out of participating in research during informed consent to perform PGT
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Genomic Prediction Clinical Laboratory | North Brunswick | New Jersey | United States | 08902 |
Sponsors and Collaborators
- Genomic Prediction Inc.
Investigators
- Principal Investigator: Nathan R Treff, PhD, Genomic Prediction
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- Genomic Prediction Inc 609